Analytical validation of eight methods of thyroglobulin measurement in fine-needle aspiration washouts.


Journal

Annals of clinical biochemistry
ISSN: 1758-1001
Titre abrégé: Ann Clin Biochem
Pays: England
ID NLM: 0324055

Informations de publication

Date de publication:
01 2021
Historique:
pubmed: 8 10 2020
medline: 27 5 2021
entrez: 7 10 2020
Statut: ppublish

Résumé

Thyroglobulin (Tg) assay in washout fluids of fine needles, after cervical lymph nodes aspiration, is used for detecting metastases from differentiated thyroid carcinomas. Assay methods are the same as for Tg in serum. However, with non-serum samples, methods require extensive validation to notably check for the absence of matrix effect. This study fits this context. Our objectives were to assess analytic performances, in washout fluid, of eight different Tg assay methods and to compare them to validated data in serum. Eleven medical laboratories participated in this study. The matrix tested was phosphate-buffer saline containing 1% bovine serum albumin (PBS-1% BSA). Samples used were dilutions, in this buffer, of Certified Reference Material (CRM 457). We verified, for all methods, the limit of detection, precision, linearity, trueness and accuracy. In PBS-1% BSA, the functional sensitivities (FS) were comparable to those expected for serum. All the methods were linear. The relative biases of trueness were between -24.5 and 10.2% around 1  No quantitatively important matrix effect was observed. All the methods showed their ability to measure Tg in PBS-1% BSA, over the concentration range of interest, with acceptable total analytical error. We validated the functional sensitivity value as a decision threshold in thyroidectomized patients after treatment and with low concentrations of serum Tg.

Sections du résumé

BACKGROUND
Thyroglobulin (Tg) assay in washout fluids of fine needles, after cervical lymph nodes aspiration, is used for detecting metastases from differentiated thyroid carcinomas. Assay methods are the same as for Tg in serum. However, with non-serum samples, methods require extensive validation to notably check for the absence of matrix effect. This study fits this context. Our objectives were to assess analytic performances, in washout fluid, of eight different Tg assay methods and to compare them to validated data in serum.
METHODS
Eleven medical laboratories participated in this study. The matrix tested was phosphate-buffer saline containing 1% bovine serum albumin (PBS-1% BSA). Samples used were dilutions, in this buffer, of Certified Reference Material (CRM 457). We verified, for all methods, the limit of detection, precision, linearity, trueness and accuracy.
RESULTS
In PBS-1% BSA, the functional sensitivities (FS) were comparable to those expected for serum. All the methods were linear. The relative biases of trueness were between -24.5 and 10.2% around 1 
CONCLUSION
No quantitatively important matrix effect was observed. All the methods showed their ability to measure Tg in PBS-1% BSA, over the concentration range of interest, with acceptable total analytical error. We validated the functional sensitivity value as a decision threshold in thyroidectomized patients after treatment and with low concentrations of serum Tg.

Identifiants

pubmed: 33026828
doi: 10.1177/0004563220968369
doi:

Substances chimiques

Neoplasm Proteins 0
Thyroglobulin 9010-34-8

Types de publication

Journal Article Validation Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

54-65

Auteurs

Florence Boux de Casson (F)

Service de Biochimie et Biologie Moléculaire, Centre Hospitalier Universitaire, Angers, France.
Groupe de Biologie Spécialisée de la Société Française de Médecine Nucléaire, Paris, France.

Rémi Beloeil (R)

Laboratoire IHE/BMGS et Service DEL/DIS, Etablissement Français du Sang Bretagne, Brest, France.

Anne-Sophie Gauchez (AS)

Groupe de Biologie Spécialisée de la Société Française de Médecine Nucléaire, Paris, France.
Plateforme de Radioactivité, Centre Hospitalier Universitaire Grenoble - Alpes, UMR-S INSERM 1039, Grenoble, France.
Service de Médecine Nucléaire, Centre Hospitalier Métropole Savoie, Chambéry, France.

Charlotte Oris (C)

Service de Biochimie, Centre Hospitalier Universitaire, Clermont-Ferrand, France.

Monique Leban (M)

Groupe de Biologie Spécialisée de la Société Française de Médecine Nucléaire, Paris, France.
Département de Biochimie Hormonale, Centre Hospitalier Universitaire Pitié-Salpêtrière, AP-HP, Paris, France.

Marie-Hélène Schlageter (MH)

Groupe de Biologie Spécialisée de la Société Française de Médecine Nucléaire, Paris, France.
Laboratoire de Biologie Cellulaire, Hôpital Saint-Louis, AP-HP, Paris, France.

Marie-Pierre Moineau (MP)

Groupe de Biologie Spécialisée de la Société Française de Médecine Nucléaire, Paris, France.
Département de Biochimie et Pharmacologie Toxicologie, Centre Hospitalier Universitaire, Brest, France.

Diane Dufour-Rainfray (D)

Groupe de Biologie Spécialisée de la Société Française de Médecine Nucléaire, Paris, France.
UMR 1253, iBrain, Université de Tours, Inserm, Tours, France.

Kalyane Bach-Ngohou (K)

Groupe de Biologie Spécialisée de la Société Française de Médecine Nucléaire, Paris, France.
Département de Biochimie, Centre Hospitalier Universitaire, Université INSERM U1235, Nantes, France.

Karim Chikh (K)

Groupe de Biologie Spécialisée de la Société Française de Médecine Nucléaire, Paris, France.
Laboratoire de Biochimie et Biologie Moléculaire, Centre de Biologie Sud, Centre Hospitalier Lyon Sud, ISPB - Faculté de Pharmacie, Laboratoire CARMEN, Lyon, France.

Valérie Moal (V)

Service de Biochimie et Biologie Moléculaire, Centre Hospitalier Universitaire, Angers, France.
Groupe de Biologie Spécialisée de la Société Française de Médecine Nucléaire, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH